发明名称 Alkoxy substituted imidazoquinolines
摘要 Imidazoquinoline compounds with an alkoxy substituent at the 6, 7, 8, or 9-position, pharmaceutical compositions containing the compounds, intermediates, methods of making, and methods of use of these compounds as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animals and in the treatment of diseases including viral, and neoplastic, are disclosed.
申请公布号 US9365567(B2) 申请公布日期 2016.06.14
申请号 US201414502157 申请日期 2014.09.30
申请人 3M Innovative Properties Company 发明人 Lindstrom Kyle J.;Merrill Bryon A.;Haraldson Chad A.;Rice Michael J.;Kshirsagar Tushar A.;Heppner Philip D.;Wurst Joshua R.;Niwas Shri;Slania Sarah J.
分类号 C07D471/04;A61K31/4745;C07D413/14 主分类号 C07D471/04
代理机构 代理人
主权项 1. A compound of the formula (II):wherein: R3 is selected from the group consisting of —Z—Y3—R4-3,—Z—Y3—X3—Y3—R4-3,—Z-Het,—Z-Het′-R4, and—Z-Het′-Y—R4; Z is selected from the group consisting of alkylene, alkenylene, and alkynylene, wherein alkylene, alkenylene, and alkynylene can be optionally interrupted with one or more —O— groups; Y3 is selected from the group consisting of: —S(O)0-2—,—C(R6)—,—C(R6)—O—,—O—C(R6)—, and—O—C(O)—O—; R is selected from the group consisting of alkyl, alkoxy, hydroxy, halogen, and trifluoromethyl; n is 0 or 1; R1 is selected from the group consisting of alkyl, alkoxyalkylenyl, aminoalkylenyl, hydroxyalkylenyl, dihydroxyalkylenyl and alkyl substituted by a group selected from the group consisting of —NH—C(O)-alkyl, —NH—S(O)2-alkyl, —NH—C(O)—NH-alkyl, —NH—C(O)—O-alkyl, phenoxy, tetrahydropyranyl, 1,1-dioxidoisothiazolidin-2-yl, and 2,2-dimethyl-1,3-dioxolan-4-yl; R2 is selected from the group consisting of hydrogen, alkyl, alkoxyalkylenyl, and hydroxyalkylenyl; X3 is selected from the group consisting of alkylene, alkenylene, alkynylene, arylene, heteroarylene, and heterocyclylene wherein the alkylene, alkenylene, and alkynylene groups can be optionally interrupted or terminated with arylene, heteroarylene, or heterocyclylene, and optionally interrupted by one or more —O— groups, wherein heterocyclylene is non-aromatic and contains at least one ring heteroatom, wherein the at least one ring heteroatom is selected from the group consisting of an oxygen atom and a sulfur atom; Y is selected from the group consisting of —S(O)0-2—,—S(O)2—N(R8)—,—C(R6)—,—C(R6)—O—,—O—C(R6)—,—O—C(O)—O—,—N(R8)-Q-,—C(R6)—N(R8)—,—O—C(R6)—N(R8)—,—C(R6)—N(OR9)—, R4 is selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, aryl, arylalkylenyl, aryloxyalkylenyl, alkylarylenyl, heteroaryl, heteroarylalkylenyl, heteroaryloxyalkylenyl, alkylheteroarylenyl, and heterocyclyl wherein the alkyl, alkenyl, alkynyl, aryl, arylalkylenyl, aryloxyalkylenyl, alkylarylenyl, heteroaryl, heteroarylalkylenyl, heteroaryloxyalkylenyl, alkylheteroarylenyl, and heterocyclyl groups can be unsubstituted or substituted by one or more substituents independently selected from the group consisting of alkyl, alkoxy, hydroxyalkyl, haloalkyl, haloalkoxy, halogen, nitro, hydroxy, mercapto, cyano, aryl, aryloxy, arylalkyleneoxy, heteroaryl, heteroaryloxy, heteroarylalkyleneoxy, heterocyclyl, amino, alkylamino, dialkylamino, (dialkylamino)alkyleneoxy, and in the case of alkyl, alkenyl, alkynyl, and heterocyclyl, oxo; R4-3 is selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, aryl, arylalkylenyl, aryloxyalkylenyl, alkylarylenyl, heteroaryl, heteroarylalkylenyl, heteroaryloxyalkylenyl, alkylheteroarylenyl, and heterocyclyl wherein the alkyl, alkenyl, alkynyl, aryl, arylalkylenyl, aryloxyalkylenyl, alkylarylenyl, heteroaryl, heteroarylalkylenyl, heteroaryloxyalkylenyl, alkylheteroarylenyl, and heterocyclyl groups can be unsubstituted or substituted by one or more substituents independently selected from the group consisting of alkyl, alkoxy, hydroxyalkyl, haloalkyl, haloalkoxy, halogen, nitro, hydroxy, mercapto, cyano, aryl, aryloxy, arylalkyleneoxy, heteroaryl, heteroaryloxy, heteroarylalkyleneoxy, heterocyclyl, amino, alkylamino, dialkylamino, (dialkylamino)alkyleneoxy, and in the case of alkyl, alkenyl, alkynyl, and heterocyclyl, oxo, wherein heterocyclyl is non-aromatic and contains at least one ring heteroatom, and wherein the at least one ring heteroatom is selected from the group consisting of an oxygen atom and a sulfur atom; R6 is selected from the group consisting of ═O and ═S; R7 is C2-7 alkylene; R8 is selected from the group consisting of hydrogen, alkyl, alkoxyalkylenyl, and arylalkylenyl; R9 is selected from the group consisting of hydrogen and alkyl; R10 is C3-8 alkylene; Het is a non-aromatic heterocyclyl that contains at least one ring heteroatom, wherein the at least one ring heteroatom is selected from the group consisting of an oxygen atom and a sulfur atom, and wherein the non-aromatic heterocyclyl can be unsubstituted or substituted by one or more substituents independently selected from the group consisting of alkyl, alkoxy, haloalkyl, haloalkoxy, halogen, nitro, hydroxy, hydroxyalkyl, mercapto, cyano, aryloxy, arylalkyleneoxy, heteroaryloxy, heteroarylalkyleneoxy, heterocyclyl, hydroxyalkyleneoxyalkylenyl, amino, alkylamino, dialkylamino, (dialkylamino)alkyleneoxy, and oxo; Het′ is a non-aromatic heterocyclylene that contains at least one ring heteroatom, wherein the at least one ring heteroatom is selected from the group consisting of an oxygen atom and a sulfur atom, and wherein the non-aromatic heterocyclyl can be unsubstituted or substituted by one or more substituents independently selected from the group consisting of alkyl, alkoxy, haloalkyl, haloalkoxy, halogen, nitro, hydroxy, hydroxyalkyl, mercapto, cyano, aryloxy, arylalkyleneoxy, heteroaryloxy, heteroarylalkyleneoxy, amino, alkylamino, dialkylamino, (dialkylamino)alkyleneoxy, and oxo; Q is selected from the group consisting of a bond, —C(R6)—, —C(R6)—C(R6)—, —S(O)2—, —C(R6)—N(R8)—W—, —S(O)2—N(R8)—, —C(R6)—O—, and —C(R6)—N(OR9)—; V is selected from the group consisting of —C(R6)—, —O—C(R6)—, —N(R8)—C(R6)—, and —S(O)2—; W is selected from the group consisting of a bond, —C(O)—, and —S(O)2—; and with the proviso that Z can also be a bond when: R3 is —Z-Het, —Z-Het′-R4, or —Z-Het′-Y—R4; orR3 is —Z—Y3—R4 or —Z—Y3—X—Y3—R4, and Y3 is selected from —S(O)0-2—, —C(R6)—, and —C(R6)—O—;or a pharmaceutically acceptable salt thereof.
地址 St. Paul MN US